AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Roche enters a research partnership with Atavistik Bio with a USD 70 million upfront payment.
Sep 25, 2026
Contract Type
partnership
CambridgeBiotechnologySoftwareHealth CareScience And Engineering
Description
Roche has made a significant investment by paying Atavistik Bio USD 70 million upfront as part of a research partnership. This partnership aims to advance innovative drug discovery efforts.
Company Information
Company
Atavistik Bio
Location
Cambridge, England, United Kingdom
About
Atavistik Bio (Atavistik) is a pre-clinical stage biotechnology company pioneering the identification of allosteric small molecule-protein interactions that have the potential to lead to the discovery and future clinical development of first-in-class drug compounds within oncology and metabolic diseases. Atavistik was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Led by an experienced management team and advisors, plus a robust investment syndicate, Atavistik is positioned to deliver transformational science to ultimately improve patient care. Learn more at AtavistikBio.com.
Predictive Intelligence
Strategic
ML-powered predictions for Atavistik Bio's next move